Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
3526
Adaptimmune Therapeutics
ADAP
$13M
| $49K | ﹤0.01% |
50,061
| – | – |
|
3527
iShares Asia 50 ETF
AIA
$967M
| $49K | ﹤0.01% |
725
| – | – |
|
|
ELEV
3528
DELISTED
Elevation Oncology
ELEV
| $49K | ﹤0.01% |
+17,910
| New | +$49K |
|
3529
iShares MSCI Poland ETF
EPOL
$455M
| $49K | ﹤0.01% |
1,985
| – | – |
|
3530
InfuSystem Holdings
INFU
$213M
| $49K | ﹤0.01% |
7,140
-6,074
| -46% | -$41.7K |
|
3531
NN Inc
NNBR
$126M
| $49K | ﹤0.01% |
+16,116
| New | +$49K |
|
3532
ProPhase Labs
PRPH
$21.4M
| $49K | ﹤0.01% |
+11,767
| New | +$49K |
|
3533
Stratus Properties
STRS
$156M
| $49K | ﹤0.01% |
1,924
-1,993
| -51% | -$50.8K |
|
3534
Tilray
TLRY
$1.25B
| $49K | ﹤0.01% |
29,147
-137,781
| -83% | -$232K |
|
|
SBT
3535
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $49K | ﹤0.01% |
9,089
-6,291
| -41% | -$33.9K |
|
3536
iShares MSCI Philippines ETF
EPHE
$103M
| $48K | ﹤0.01% |
+1,994
| New | +$48K |
|
3537
Astera Labs
ALAB
$35.7B
| $48K | ﹤0.01% |
788
-4,112
| -84% | -$250K |
|
3538
American Well
AMWL
$112M
| $47K | ﹤0.01% |
7,368
-4,931
| -40% | -$31.5K |
|
3539
iShares MSCI EAFE Value ETF
EFV
$28B
| $47K | ﹤0.01% |
890
-18,046
| -95% | -$953K |
|
3540
Eastern Company
EML
$147M
| $47K | ﹤0.01% |
+1,820
| New | +$47K |
|
3541
Paysign
PAYS
$295M
| $47K | ﹤0.01% |
11,019
-11,720
| -52% | -$50K |
|
3542
Peoples Bancorp of North Carolina
PEBK
$168M
| $47K | ﹤0.01% |
1,590
+1,449
| +1,028% | +$42.8K |
|
3543
ThredUp
TDUP
$1.37B
| $47K | ﹤0.01% |
27,465
-24,219
| -47% | -$41.4K |
|
3544
Twin Disc
TWIN
$189M
| $47K | ﹤0.01% |
3,904
-10,755
| -73% | -$129K |
|
3545
Ginkgo Bioworks
DNA
$637M
| $46K | ﹤0.01% |
3,447
-6,227
| -64% | -$83.1K |
|
3546
Future Fuel
FF
$175M
| $46K | ﹤0.01% |
8,864
-9,760
| -52% | -$50.7K |
|
3547
ESS Tech
GWH
$19.2M
| $46K | ﹤0.01% |
3,820
-472
| -11% | -$5.68K |
|
3548
Invivyd
IVVD
$255M
| $46K | ﹤0.01% |
42,193
-160,638
| -79% | -$175K |
|
|
NAGE
3549
Niagen Bioscience, Inc. Common Stock
NAGE
$754M
| $46K | ﹤0.01% |
+16,600
| New | +$46K |
|
3550
Cadiz
CDZI
$303M
| $45K | ﹤0.01% |
14,489
-14,063
| -49% | -$43.7K |
|